Skip to main content

Table 3 Adjusted mean total all-cause costs (excluding DMT costs) in year 2010 a

From: Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity

 

Mean

Standard error

Upper level of 95% CI

Lower level of 95% CI

HRA group

$26,803.19

$1126.41

$24,478.92

$28,793.61

Non-HRA group

$14,745.85

$211.09

$14,365.36

$15,140.86

Cost difference

12,057.34

$1149.85

$9,716.94

$14,073.66

  1. aBootstrapping: repeat 200; bias correction method.
  2. HRA=high relapse activity; CI=confidence interval.